Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.

Stewart LE, Beck TL, Giannakopoulos NV, Rendi MH, Isacson C, Goff BA.

Gynecol Oncol. 2018 May;149(2):297-300. doi: 10.1016/j.ygyno.2018.03.008. Epub 2018 Mar 11.

PMID:
29534832
2.
3.

Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva.

Xing D, Bakhsh S, Melnyk N, Isacson C, Ho J, Huntsman DG, Gilks CB, Ronnett BM, Horlings HM.

Int J Gynecol Pathol. 2017 May;36(3):289-293. doi: 10.1097/PGP.0000000000000324.

PMID:
27662035
4.

A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.

Paley PJ, Veljovich DS, Press JZ, Isacson C, Pizer E, Shah C.

Am J Obstet Gynecol. 2016 Jul;215(1):117.e1-7. doi: 10.1016/j.ajog.2015.12.046. Epub 2015 Dec 29.

PMID:
26743505
5.

Lower Female Genital Tract Tumors With Adenoid Cystic Differentiation: P16 Expression and High-risk HPV Detection.

Xing D, Schoolmeester JK, Ren Z, Isacson C, Ronnett BM.

Am J Surg Pathol. 2016 Apr;40(4):529-36. doi: 10.1097/PAS.0000000000000565.

PMID:
26645728
6.

The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.

Kandalaft PL, Gown AM, Isacson C.

Am J Clin Pathol. 2014 Dec;142(6):830-6. doi: 10.1309/AJCP8WO2EOIAHSOF.

PMID:
25389337
7.

An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.

Vogel TJ, Knickerbocker A, Shah CA, Schiff MA, Isacson C, Garcia RL, Goff BA.

J Gynecol Oncol. 2015 Jan;26(1):25-31. doi: 10.3802/jgo.2015.26.1.25. Epub 2014 Nov 6.

8.

Urothelial carcinoma involving the gynecologic tract: a morphologic and immunohistochemical study of 6 cases.

Reyes MC, Park KJ, Lin O, Ioffe O, Isacson C, Soslow RA, Reuter VE, Fine SW.

Am J Surg Pathol. 2012 Jul;36(7):1058-65. doi: 10.1097/PAS.0b013e318251eade.

PMID:
22510759
9.

Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture.

Lace MJ, Isacson C, Anson JR, Lörincz AT, Wilczynski SP, Haugen TH, Turek LP.

J Virol. 2009 Aug;83(15):7457-66. doi: 10.1128/JVI.00285-09. Epub 2009 May 20.

10.

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer.

Vuky J, Porter C, Isacson C, Vaughan M, Kozlowski P, Picozzi V, Corman J.

Cancer. 2009 Feb 15;115(4):784-91. doi: 10.1002/cncr.24092.

12.

RACK1 is a BKCa channel binding protein.

Isacson CK, Lu Q, Karas RH, Cox DH.

Am J Physiol Cell Physiol. 2007 Apr;292(4):C1459-66. Epub 2006 Dec 13.

13.

Adenocarcinoma of the testicular adnexa presenting with metastatic disease.

Joos ZP, Pritchett TR, Porter CR, Isacson C, Picozzi V, Corman JM.

Can J Urol. 2006 Feb;13(1):2990-2. Review.

PMID:
16515756
14.

Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma.

Vuky J, Isacson C, Fotoohi M, dela Cruz J, Otero H, Picozzi V, Malpass T, Aboulafia D, Jacobs A.

Invest New Drugs. 2006 Jan;24(1):85-8.

PMID:
16380835
15.

Molecular characterization of uterine clear cell carcinoma.

An HJ, Logani S, Isacson C, Ellenson LH.

Mod Pathol. 2004 May;17(5):530-7.

16.

The significance of psammoma bodies in screening cervical cytologic smears.

Muntz HG, Goff BA, McGonigle K, Isacson C.

Am J Obstet Gynecol. 2003 Jun;188(6):1609-12; discussion 1612-4.

PMID:
12825000
18.

A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component.

Slomovitz BM, Caputo TA, Gretz HF 3rd, Economos K, Tortoriello DV, Schlosshauer PW, Baergen RN, Isacson C, Soslow RA.

Am J Surg Pathol. 2002 May;26(5):592-600.

PMID:
11979089
19.

Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection.

Pirog EC, Isacson C, Szabolcs MJ, Kleter B, Quint W, Richart RM.

Int J Gynecol Pathol. 2002 Jan;21(1):22-6.

PMID:
11781519
20.

Diagnostic Accuracy of Cervical Low-Grade Squamous Intraepithelial Lesions Is Improved With MIB-1 Immunostaining.

Pirog EC, Baergen RN, Soslow RA, Tam D, DeMattia AE, Chen YT, Isacson C.

Am J Surg Pathol. 2002 Jan;26(1):70-5.

PMID:
11756771
21.

Early uterine serous carcinoma: clonal origin of extrauterine disease.

Baergen RN, Warren CD, Isacson C, Ellenson LH.

Int J Gynecol Pathol. 2001 Jul;20(3):214-9.

PMID:
11444195
22.

Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia.

Newfield RS, Spitz IM, Isacson C, New MI.

Clin Endocrinol (Oxf). 2001 Mar;54(3):399-404.

PMID:
11298094
23.

Cyclin D1 expression in high-grade endometrial carcinomas--association with histologic subtype.

Soslow RA, Shen PU, Chung MH, Isacson C, Baergen RN.

Int J Gynecol Pathol. 2000 Oct;19(4):329-34.

PMID:
11109161
24.

MIB-1 immunostaining is a beneficial adjunct test for accurate diagnosis of vulvar condyloma acuminatum.

Pirog EC, Chen YT, Isacson C.

Am J Surg Pathol. 2000 Oct;24(10):1393-9.

PMID:
11023101
25.

Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C.

Am J Pathol. 2000 Oct;157(4):1055-62.

26.

Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis.

Soslow RA, Pirog E, Isacson C.

Am J Surg Pathol. 2000 May;24(5):726-32.

PMID:
10800992
27.

Atypical immature metaplasia (AIM) of the cervix: is it related to high-grade squamous intraepithelial lesion (HSIL)?

Geng L, Connolly DC, Isacson C, Ronnett BM, Cho KR.

Hum Pathol. 1999 Mar;30(3):345-51.

PMID:
10088555
28.

Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.

Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, Kurman RJ.

Am J Surg Pathol. 1998 Aug;22(8):1012-9.

PMID:
9706982
29.
30.

The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype.

Soslow RA, Shen PU, Isacson C, Chung MH.

Mod Pathol. 1998 Feb;11(2):194-9. Erratum in: Mod Pathol 1998 Apr;11(4):375.

PMID:
9504691
31.

Squamous metaplasia of the endometrium associated with HPV 6 and 11.

Sherwood JB, Carlson JA, Gold MA, Chou TY, Isacson C, Talerman A.

Gynecol Oncol. 1997 Jul;66(1):141-5.

PMID:
9234935
32.

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L.

Am J Pathol. 1997 Jan;150(1):177-85.

33.

Microsatellite instability is uncommon in uterine serous carcinoma.

Tashiro H, Lax SF, Gaudin PB, Isacson C, Cho KR, Hedrick L.

Am J Pathol. 1997 Jan;150(1):75-9.

34.

Ultrasonic surgical aspiration to treat genital condyloma acuminata in children.

Smith YR, Isacson C, Namnoum AB.

J Pediatr Adolesc Gynecol. 1996 Aug;9(3):145-7.

PMID:
8795791
35.

Large cervical adenomyoma occurring in a first-trimester gravid uterus: radiologic-pathology correlation.

Athas JM, Bluemke DA, Isacson C, Sheth S.

AJR Am J Roentgenol. 1996 Aug;167(2):514-5. No abstract available.

PMID:
8686639
36.

Telecytology: diagnostic accuracy in cervical-vaginal smears.

Raab SS, Zaleski MS, Thomas PA, Niemann TH, Isacson C, Jensen CS.

Am J Clin Pathol. 1996 May;105(5):599-603.

PMID:
8623769
37.
38.

Ambiguous genitalia in an elderly woman with a mosaic 45,X/46,X,dic(Y)(Q11.2) karyotype.

Smith YR, Stetten G, Charity L, Isacson C, Gearhart JP, Namnoum AB.

Urology. 1996 Feb;47(2):259-62. Review.

PMID:
8607249
39.

Atypical glandular cells of undetermined significance. Cytologic criteria to separate clinically significant from benign lesions.

Raab SS, Isacson C, Layfield LJ, Lenel JC, Slagel DD, Thomas PA.

Am J Clin Pathol. 1995 Nov;104(5):574-82.

PMID:
7572819
40.

Are ThinPrep smears better than Papanicolaou smears in practice?

Isacson C, Cohen MB.

Am J Clin Pathol. 1994 Oct;102(4):557-8. No abstract available.

PMID:
7818678
41.

Coacute heparin: a new simple monotest for monitoring heparin treatment.

Friberger P, Urig E, Eriksson-Skoog L, Svensson S, Isacson C.

Semin Thromb Hemost. 1994;20(4):328-32.

PMID:
7899863
42.

Coacute heparin: a new simple monotest for monitoring heparin treatment.

Friberger P, Krig E, Eriksson-Skoog L, Svensson S, Isacson C.

Semin Thromb Hemost. 1993;19 Suppl 1:86-9.

PMID:
8362270
43.

Characterization of prolactin immunoreactivity in human cerebrospinal fluid.

Nyberg F, Isacson CA, Brostedt E, Roos P.

Brain Res. 1990 Jan 1;506(1):129-32.

PMID:
2302549
44.

32P-pyrophosphate in the treatment of persistent metastatic bone pain.

Werner B, Isacson C, Lundell G, Lönnbeck C, Söderborg B.

Acta Radiol Oncol. 1980;19(5):327-9.

PMID:
6163323

Supplemental Content

Loading ...
Support Center